Best Lymphoma doctors: TOP 90 doctors

Prof. Dr. Serdar Bedii Omay is a respected hematologist. He specializes in Hematology and Bone Marrow Transplantation. He graduated from Hacettepe Medical School in 1985. He completed his Internal Medicine training at Ege University in 1990. He earned his PhD in Hematology at Japan Mie Medical School in 1995.

Dr. Omay has published 65 scientific articles, 112 meeting papers, and 34 international conference presentations. He has served as a professor at Ege University and Karadeniz Technical University. He also worked as a Hematology Specialist and Molecular Hematology Doctor in Japan. His career shows strong expertise and international recognition in his field.

Prof. Dr. Birol Baytan is a respected pediatric hematologist. He focuses on diagnosing and treating childhood cancers, leukemia, anemia, and bleeding disorders. He graduated from Ankara University Medical Faculty in 1992. He completed his specialization at Uludağ University Faculty of Medicine, Department of Child Diseases.

Prof. Baytan has published 15 articles in international journals. He has presented and published 9 full texts at international scientific meetings. He has contributed to 3 books or book chapters. He has also published 8 articles in local journals. These achievements show his strong academic presence in pediatric hematology.

Areas of Interest

1. Bone marrow transplantation
2. Leukemia
3. Lymphoma
4. Multiple myeloma
5. Thalassemia
6. Bone marrow diseases
7. Plasmapheresis

Education
2005 Graduated from Hacettepe University, Faculty of Medicine
2010 Hacettepe University, Faculty of Medicine Internal Medicine Specialist
2014 Ankara University, Faculty of Medicine Hematology Specialist

Experience
October 2010 - December 2010 Internal Medicine Specialist at Ankara Oncology Hospital
December 2010 - April 2011 Hematology Sub-branch Assistant at Ankara Oncology Hospital
September 2014 - May 2016 Hematology Specialist at Kütahya Dumlupınar University Evliya Çelebi Training and Research Hospital
May 2016 - March 2018 Ufuk University, Faculty of Medicine, Hematology Department Faculty Member
March 2018 - October 2018 Hitit University, Faculty of Medicine, Hematology Department Faculty Member
November 2018 - January 2019 Medical Park Bahçelievler Hematology and Bone Marrow Transplantation Unit physician
February 2019 - June 2022 Present Bayındır Söğütözü Hospital Hematology and Stem Cell Transplantation Unit, Assistant Physician in Charge
June 2022 - July 2022 Afyonkarahisar Health Sciences University, Head of Hematology Department

Qualification Certificates
Internal Medicine Board Qualification Certificate, 2009
Hematology Board Qualification Certificate, 2014
English Proficiency 2017/7 e-YDS Score: 71.25
Internal Medicine Specialization Thesis Addition of 9-Week Trastuzumab to Adjuvant Treatment in Both Positive Breast Cancer Patients Retrospective Analysis

Education Abroad
Between October and December 2007 (3 months) Intensive Care Education at University of Florida, United States
Between December 2013 and January 2014 (2 months) Flow Cytometry Education at Salamanca University, Spain

Courses, Awards, and Certificates
1 Year of Work Certificate in Bone Marrow Transplantation, 2017
Blood Banking and Transfusion Medicine Certificate 2017
“Physician of the Year” Award in Kütahya, 2014
Laboratory GMP, GLP, ISO /IEC 17025: 2012 Certificates, 2014
Good Clinical Practices Certificate, 2013
Şeref Zileli Successful Assistant of the Year Award, 2009
RIA Certificate, 2005

Research and Publications

Patent
1. Half antibody with the fc portion removed (fab) for medical use. Inventor: Mehmet Özen. No:2016/0910. Patent under review.

Scientific Studies
A. Publications in International Journals under SCI Expanded


 Turkish book section

1. Ozen M, Konuk N. Immune thrombocytopenic purpura. Turkoz Sucak G, editor. Current Topics in Immunohematology. 1st Edition. Ankara: Turkey Clinics; 2021. p.8-12.

2. Özen M, Ural AU. Hematological diseases and mesenchymal stem cell applications. Türköz Sucak G, editor. Current Topics in Immunohematology. 1st Edition. Ankara: Turkey Clinics; 2021. p.91-4.

3. Ozen M. Hematopoiesis and Hematopoietic Growth Factors. MediHealth & Hippocrates INTERNAL DISEASES with Current Guidelines 2022. p1607-10

• Dr. Bertram Glaß specializes in treating Lymphoma.
• Head of Hematology and Stem Cell Transplant at Helios Berlin-Buch.
• Utilizes chemotherapy, radiotherapy, and stem cell transplantation.
• International experience in Germany at leading medical institutions.
• Engages in clinical research for malignant lymphoma treatments.
• Member of The American Society of Clinical Oncology, highlighting oncological expertise.
• Fluent in German, offering consultations in native language.

Dr. Girish V. Badarkhe is a hematology-oncologist at HCG Manavata Cancer Centre in Nashik. He has over 13 years of clinical experience. He treats leukemia, multiple myeloma, and performs bone marrow transplants. Dr. Badarkhe has managed many complex cases with strong results.

He earned his MBBS from Grant Medical College. He completed his MD in Pathology at Lokmanya Tilak Municipal Medical College and his DM in Clinical Hematology at Medical College, Calcutta. Dr. Badarkhe has received several awards for his work and dedication in hematology-oncology.

Dr. Siret Ratip is a hematologist and oncologist with over 25 years of clinical experience. He focuses on internal medicine and hematology. He has worked as an associate professor at respected institutions, including University College Hospital in London.

Dr. Ratip is a member of the British Hematology Committee and the Hematology Federation of Turkey. He has performed many advanced procedures, such as autologous and allogenic bone marrow transplantation, bone marrow aspiration, and biopsy. He has made important contributions to patient care and research in thalassemia.

She completed her training at the Charité in Berlin and has been a specialist in radiotherapy for 20 years. She worked as a senior physician in all departments of the Charité in Berlin, and from 2007 to 2015 she was a senior physician and deputy director of the Charité clinic in Berlin. In 2015, she was appointed head of the department of radiotherapy at the University Hospital of Cologne and very successfully headed the clinic there until 2022. Since the end of 2022, she has been heading the private radiotherapy clinic "RadioOnkologie Vosspalais". Clinical areas include radioimmunotherapy, high-precision therapy, multimodal therapy of gynecological tumors and prostate carcinoma.

Professor Dr. Marnitz is a member of the German and European Guidelines for the Therapy of Endometrial Carcinoma. She is also an independent external expert of the European Council for the Therapy of Carcinoma of the Cervical, Vulvar and Vaginal Cancer. Professor Dr. Marnitz is a member of the German and European Guidelines for the Therapy of Endometrial Carcinoma. She is also an independent external expert of the European Council for the Therapy of Carcinoma of the Cervical, Vulvar and Vaginal Cancer. Several randomized clinical trials have been conducted under her leadership.

Professor Dr. Marnitz is an honorary member of the Russian Society of Gynecological Oncology, a member of the professional societies DEGRO, ESTRO, ASTRO. In 2024, Professor Dr. Marnitz will be the president of the congress of the annual conference of the German Society of Radiation Oncology.

Prof. Dr. med. Volker Budach *Prof. Dr.med. Volker Budach

He completed his medical studies at the University of Essen and was appointed to the Department of Radiotherapy at the Charité Hospital in Berlin in 1993. He successfully headed this department until 2022, with almost 40 years of professional and 30 years of managerial experience. Under the direction of Prof. Dr. Budach, numerous clinical studies were conducted, especially in the therapy of head and neck tumors. Along with other tumors such as sarcomas, bronchial carcinomas and breast carcinomas, which are his clinical and scientific focus. Prof. Dr. Budach founded and for many years jointly directed the comprehensive cancer center at the Charité. In addition to his function as director of the clinic, he also headed the Charité Center 14, which combined the topics of imaging and oncology. Prof. Budach was President of the German Society for Radiation Oncology (DEGRO) and President of its congress. At the EORTC, he headed the head and neck tumour group for many years. He is the author of numerous important papers on the optimisation of radiotherapy and chemotherapy in the treatment of head and neck tumours. After 30 years of leading the clinic, Prof. Dr. Budach decided to transfer his experience in radiation oncology to the RadioOnkologie Vosspalais clinic. Prof. Dr. Budach is a member of the professional associations DEGRO, ESTRO, ASTRO.

Prof. Dr. Songul Serefhanoglu is a leading hematologist. She is the Director and President of the Adult Hematology Department at Sisli Memorial Hospital in Istanbul, a role she has held since 2019. She also practices at ISU Medical Park. Dr. Serefhanoglu specializes in peripheral hematopoietic stem cell transplantation. Each year, she performs 100-120 transplants, including 60-70 allogenic and 40-50 autologous procedures.

Dr. Serefhanoglu earned her medical degree from Firat University. She completed her residency in Internal Medicine at Inonu University and her hematology training at Hacettepe University. She became an Associate Professor in 2012 and a full Professor in 2018. Dr. Serefhanoglu has held leadership positions in several major hospitals in Istanbul, demonstrating her expertise in hematology.

• Dr. Jorg Groticke specializes in cutting-edge Lymphoma treatment.
• Treatment methods include chemotherapy, targeted therapy, and immunotherapy.
• International practice in Germany, renowned for cancer care excellence.
• Holds certifications in Internal Medicine and Hematology.
• Member of German Cancer Society, providing specialized care standards.
• Offers remote consultations for Lymphoma patients internationally.
• Speaks English and German, facilitating communication with diverse patients.

Head of the Bone Marrow Transplantation Department, Hematologist

Pediatric hematologist-oncologist, bone marrow transplant specialist

Prof. Dr. med. Ulrich Graven

Head of the Clinic of Hematology, Oncology and Gastroenterology

Head of a certified oncology center

Head of Clinical Research Department

Specialization:

Hematology, including stem cell transplantation

Abdominal oncology, especially colorectal and pancreatic cancer therapy

Metastasis therapy, including the use of off-label drugs

Membership in professional societies:

Professional Union of German Therapists

German Society for Internal Medicine

German Cancer Society

Abdominal Oncology Working Group

German Society of Hematology and Oncology

German Working Group on Bone Marrow and Hematopoietic Stem Cell Transplantation

German Society for Digestive and Metabolic Diseases

European Society for Medical Oncology

American Society of Clinical Oncology

American Association for Cancer Research

Activities in professional communities:

German Cancer Society:

Since 2013, speaker of the commission for certification of oncology centers

Since November 2007, member of the board

Since September 2022, Speaker of the Section of National Societies on Cancer Control

Chairman of the working group on abdominal oncology of the German Cancer Society, drafting clinical guidelines for the treatment of colorectal and pancreatic cancer.

Chairman of the Oncology Society of North Rhine-Westphalia.

Member of the Colorectal Cancer Clinical Guidelines Working Group, European Society for Medical Oncology.

Member of the Scientific Council, National Cancer Registry at the Robert Koch Institute.

Chairman of the Regional Cancer Registry of the State of North Rhine-Westphalia.

Leading expert for clinical research, German Research Foundation and Federal Ministry of Research and Technology.

Member of the Commission on the Use of Medicines for Therapy "Off-Label", Federal Institute of Medicines and Medical Devices.

Member of the committee for the development of clinical guidelines for colorectal cancer.

Member of the commission on the development of approaches to metastasis and the use of palliative therapy in clinical guidelines for colorectal cancer.

Reviewer of scientific journals such as Journal of Cancer Research and Clinical Oncology, Tumor Diagnostik und Therapie, Der Schmerz, BMC Pharmacology, Onkologie, Strahlentherapie und Onkologie, International Journal of Colorectal Disease, Annuals of Oncology, European Journal of Cancer.

Dr. Yener Koç is a bone marrow transplant specialist trained in the USA. He founded the Bone Marrow Transplant Center at Medicana International Istanbul. Dr. Koç has performed more than 1,900 transplants. His patients have long-term survival rates of 66-90% for different blood disorders. He keeps mortality rates low, between 0.5-9%.

Dr. Koç has written over 230 scientific articles. Since 2004, he has served as a JACIE Accreditation Inspector for European Bone Marrow Transplant Centers. He has received several awards, including the Outstanding Physician Award from Boston University and the International Healthcare Professional of the Year (UK).

Dr. Prakash Pandit is an MD in Radiation Oncology and works as a Consultant. He has expertise in advanced cancer treatments. He specializes in Tomotherapy-H, Linear Accelerator, and Brachytherapy. He provides modern care for various types of cancer.

Dr. Pandit is known for his work in radiation oncology. He uses the latest technology to help patients. He has treated many complex cases. He always maintains high standards of safety and accuracy in his treatments.